Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer

Summary

Current therapies for Stage IV adrenal gland cancer provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of Stage IV adrenal gland cancer PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with Stage IV adrenal gland cancer.

Timeline

Start

1996-08-21

Primary completion

2011-07-05

Completion

2011-07-05

Drugs

Indications